.

DBV Technologies reported 10.71M in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
DBV Technologies DBVT:US 10.71M 4.17M
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Amarin AMRN:US $ 294.66M 0.3M
Biomarin Pharmaceutical BMRN:US $ 0.19M 0M
Eleven Biotherapeutics EBIO:US $ 0.2M 0M
Esperion Therapeutics ESPR:US $ 65K 4K
Galectin Therapeutics GALT:US $ 0.06M 0M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Insmed INSM:US $ 1.2M 6K
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
United Therapeutics UTHR:US $ 0.7M 0M
YTE INCY:US $ 0.22M 0M